2023 당뇨병 진료지침: 연속혈당측정과 인슐린펌프

With the expanding use of continuous glucose monitoring (CGM) and insulin pumps worldwide, several international guidelines dedicated to diabetes technology have been developed. Recently, the Korean Diabetes Association released a new version of their clinical practice guidelines including substanti...

Full description

Saved in:
Bibliographic Details
Published in당뇨병(JKD) Vol. 24; no. 3; pp. 141 - 147
Main Authors 진상만, Sang-man Jin
Format Journal Article
LanguageKorean
Published 대한당뇨병학회 30.09.2023
Subjects
Automation
Blood glucose self-monitoring
Diabetes mellitus
Insulin infusion systems
type 1
Online AccessGet full text

Cover

More Information
Summary:With the expanding use of continuous glucose monitoring (CGM) and insulin pumps worldwide, several international guidelines dedicated to diabetes technology have been developed. Recently, the Korean Diabetes Association released a new version of their clinical practice guidelines including substantial changes in recommendations on the use of CGM and insulin pumps. Of note, continuous use of real-time CGM is now recommended to all people with diabetes using insulin, including people with type 2 diabetes using once daily basal insulin. Convincing evidence from recent automated insulin delivery (AID) trials supports the recommendation of AID as standard therapy in type 1 diabetes. This review summarizes the results of recent clinical studies on CGM and AID and their influence on the new clinical recommendations.
Bibliography:Korean Diabetes Association
ISSN:2233-7431